Deal overview

Deal overview
Price £90.00 Full version or £25.00 Light version
Publication Date Dec 03, 2018
Abstract On 3 December 2018, the quoted UK-based healthcare company GlaxoSmithKline plc ("GSK"), announced a recommended offer for TESARO Inc ("TESARO"), a US-listed oncology-focused biopharmaceutical company. The offer of $75 per share represented an aggregate enterprise value of approximately $5.1 billion. The transaction was expected to complete in the first quarter of 2019 ...
Number of pages (Full version) 9
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.016627s